Also
CryoLife Inc., which last month was forced by regulators to launch a sweeping recall of much of the human tissue it processes for transplants, said it is cutting 27% of its work force and restating its quarterly results to report a net loss.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.